Myeloma News and Research

RSS
Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

Immunosuppressant shows promise in addressing COVID-19 symptoms for patients with blood cancers

Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19

Majority of patients with mantle cell lymphoma may benefit from CAR T-cell therapy KTE-X19

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

A promising strategy to overcome drug resistance developed by blood cancer cells

A promising strategy to overcome drug resistance developed by blood cancer cells

Gero uses AI platform to identify potential anti-COVID-19 drugs

Gero uses AI platform to identify potential anti-COVID-19 drugs

Revolutionary technology could help identify more effective cancer drug combinations

Revolutionary technology could help identify more effective cancer drug combinations

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Isolating Single T-cells of Interest using an Optofluidic Platform

Isolating Single T-cells of Interest using an Optofluidic Platform

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Research reveals novel way to treat cancers using CAR T cell therapy

Research reveals novel way to treat cancers using CAR T cell therapy

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

SU2C announces international team for fighting gastric cancer

SU2C announces international team for fighting gastric cancer

Daratumumab proves effective in patients with relapsed AL amyloidosis

Daratumumab proves effective in patients with relapsed AL amyloidosis

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

Study shows potential new approach to treating two common subtypes of lymphoma

Study shows potential new approach to treating two common subtypes of lymphoma

Temperature fluctuations could give early indications of graft-versus-host disease

Temperature fluctuations could give early indications of graft-versus-host disease

Recommended amounts of physical activity associated with reduced risk for seven cancers

Recommended amounts of physical activity associated with reduced risk for seven cancers